Sunday, December 15, 2019 10:33:42 AM
"Shareholders have asked about a press schedule, now that the filings are out of the way, shortly, will have a corporate update out with the companies game plan for the future & you can expect a fairly robust press schedule."
Question, StocksGoneWild and Greenbacks: Did anyone put a gun to Greg's head to force him to make this announcement? If not, then should the stockholders have a trust in Greg's word, or not? Is his word of value, or is it merely tinsel placed on a Christmas tree?
Understand, Greg is an officer of VYST and acting PR director. Greg wouldn't be damned if he did or if he didn't if he just stated the facts truthfully and without ambiguity. It is a blight on the company when it allows an officer to state that its shareholders could "expect a fairly robust press schedule" when, the statement is ambiguous. What Greg said, in other words: "expect an almost booming press schedule." Please, it is either booming or it is not--there is no almost.
People invest on news, and if Greg hasn't the wherewithal to present the news clearly, accurately, and truthfully, then corporate needs to find someone in their ranks who knows that words do mean something.
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM